Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-06-12 Sale | 2023-06-14 6:58 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 44,020 | $2.5513 | $112,307 | 5,100,302 (Indirect Direct) | View |
2023-06-07 Sale | 2023-06-09 5:41 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 141,062 | $2.428 | $342,504 | 5,123,822 (Indirect Direct) | View |
2023-06-05 Sale | 2023-06-07 6:24 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 33,390 | $2.5262 | $84,350 | 5,264,884 (Indirect Direct) | View |
2023-06-01 Sale | 2023-06-05 4:21 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 31,531 | $2.5306 | $79,793 | 5,298,274 (Indirect Direct) | View |
2023-04-21 Sale | 2023-04-25 5:50 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 15,004 | $2.3481 | $35,231 | 5,329,805 (Indirect Direct) | View |
2023-04-19 Sale | 2023-04-21 07:57 am | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 68,743 | $2.2747 | $156,369 | 5,344,809 (Indirect Direct) | View |
2023-04-17 Sale | 2023-04-19 09:22 am | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 148,982 | $2.1434 | $319,334 | 5,413,552 (Indirect Direct) | View |
2023-03-17 Sale(A) | 2023-04-07 4:25 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 10,436 | $2.0643 | $21,543 | 5,562,534 (Indirect Direct) | View |
2023-03-03 Sale(A) | 2023-04-07 4:23 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 6,806 | $2.0559 | $13,992 | 5,572,970 (Indirect Direct) | View |
2023-03-01 Sale(A) | 2023-04-07 4:21 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 29 | $2.05 | $59 | 5,579,776 (Indirect Direct) | View |
2023-02-21 Sale(A) | 2023-04-07 4:19 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 3,500 | $2.0529 | $7,185 | 5,579,805 (Indirect Direct) | View |
2023-02-16 Sale(A) | 2023-04-07 4:17 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 6,551 | $2.0525 | $13,446 | 5,583,305 (Indirect Direct) | View |
2023-03-17 Sale | 2023-03-20 4:36 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 10,436 | $2.0643 | $21,543 | 5,562,534 (Indirect Direct) | View |
2023-03-03 Sale | 2023-03-07 4:58 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 6,806 | $2.0559 | $13,992 | 5,572,970 (Indirect Direct) | View |
2023-03-01 Sale | 2023-03-02 5:26 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 29 | $2.05 | $59 | 5,579,776 (Indirect Direct) | View |
2023-02-21 Sale | 2023-02-23 5:01 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 3,500 | $2.0529 | $7,185 | 5,579,805 (Indirect Direct) | View |
2023-02-16 Sale | 2023-02-21 11:16 am | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 6,551 | $2.0525 | $13,446 | 5,583,305 (Indirect Direct) | View |
2022-08-22 Sale | 2022-08-23 7:43 pm | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Chief Scientific Officer | 525,000 | $2.8 | $1,470,000 | 5,589,856 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-13 Option Award | 2023-06-14 6:58 pm | N/A 2033-06-13 | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Director | 20,500 | $0 | 5,100,302 (Direct) | View |
2021-11-17 Gift | 2022-02-02 6:04 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Chief Scientific Officer | 1,200,000 | $0 | 6,264,856 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 6:04 pm | N/A 2032-01-31 | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Chief Scientific Officer | 150,000 | $0 | 6,264,856 (Direct) | View |
Ownership | 2021-05-06 9:16 pm | N/A N/A | Talaris Therapeutics Inc. | TALS | Ildstad Suzanne Chief Scientific Officer 10% Owner | 0 | $0 | 6,114,856 (Direct) | View |